© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 13, 940,
July 2, 2003
© 2003 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The American Society of Clinical Oncology presented several awards at its 39th annual meeting in Chicago in May.
Career Development Awards were presented to physicians in their first, second, or third year as full-time faculty members in a university setting. Recipients receive a 3-year grant totaling $170,100 to test a hypothesis or accomplish intended research.
This year’s winners were Michele Basche, M.D., University of Colorado Health Sciences Center, Denver; Janice N. Cormier, M.D., University of Texas M. D. Anderson Cancer Center, Houston; Jakob Dupont, M.D., Memorial Sloan-Kettering Cancer Center, New York; Peter M. Ellis, M.D., Ph.D., Hamilton Regional Cancer Centre, Ontario; Andrew H. Ko, M.D., University of California at San Francisco; Mark J. Levis, M.D., Ph.D., Johns Hopkins University, Baltimore; Jeffrey A. Meyerhardt, M.D., Dana-Farber Cancer Institute, Boston; Jane E. Minturn, M.D., Ph.D., Children’s Hospital of Philadelphia; Olatoyosi M. Odenike, M.D., University of Chicago; Ann H. Partridge, M.D., Dana-Farber Cancer Institute, Boston; Manish A. Shah, M.D., Memorial Sloan-Kettering Cancer Center, New York; Donald E. Tsai, M.D., Ph.D., University of Pennsylvania; James C. Yao, M.D., M. D. Anderson Cancer Center, Houston; and Herbert Zeh III, M.D., University of Pittsburgh.
Special Awards were presented to individuals who have made substantial contributions to the practice of oncology.
This year’s winners were as follows:
Brian J. Druker, M.D., of the Oregon Health & Science University and Howard Hughes Medical Institute, received the David A. Karnofsky Memorial Award for his discovery and development of STI-571 (Gleevec).
Umberto Veronesi, M.D., of the European Institute of Oncology, received the Distinguished Service Award for Scientific Achievement for his research on minimally invasive procedures for the treatment of breast cancer.
David A. Kessler, M.D., of the Yale University School of Medicine, received the Distinguished Service Award for Scientific Leadership for his role in achieving tougher regulations for tobacco control in the United States and accelerating the new drug approval process.
Sir Richard Peto, a professor of medical statistics and epidemiology at the University of Oxford, received the Distinguished Service Award for Scientific Leadership for his research showing that tobacco is linked to cancer.
Harold P. Freeman, M.D., associate director of the National Cancer Institute and director of the NCI Center to Reduce Cancer Health Disparities, received the Special Recognition Award for his research on disparities in health care.
Ezekiel J. Emanuel, M.D., Ph.D., chair of the Department of Clinical Bioethics at the National Institutes of Health, received a Public Service Award for his involvement in increasing public awareness about cancer.
Lowell E. Schnipper, M.D., director of Clinical Affairs at Beth Israel Deaconess Cancer Center, received a Public Service Award for his support of clinical research.
Ellen L. Stovall, president and chief executive officer of the National Coalition for Cancer Survivorship, received the Partners in Progress Award for her advocacy of patient issues.
Jimmie C. Holland, M.D., chair of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center, was awarded the American Cancer Society Award Lecture for her work on the psychologic effects of cancer.
Melvyn F. Greaves, Ph.D., director of the Leukemia Research Fund Center for Cell and Molecular Biology at the Institute of Cancer Research in London, received the Pediatric Oncology Lectureship for his work in the field of pediatric leukemia.
The inaugural Clinical Trials Awards were presented to community oncology practices that actively participate in cancer research by incorporating clinical trials participation into their practices.
This year’s winners were Baptist Cancer Institute, Jacksonville, Fla.; Central Georgia Hematology Oncology Associates, Macon, Ga.; Medcenter One Health System, Bismarck, N.D.; Midwest Hematology Oncology Consultants Inc., St. Louis, Mo.; Nashville Breast Cancer Center, Nashville, Tenn.; Oncology Care Consultants, Frederick, Md.; Cotton O’Neil Clinic, Stormont Vail Health Care, Topeka, Kan.; Summa Health Systems, Akron, Ohio; and the Women’s Cancer Center at Community Hospital Los Gatos, Los Gatos, Calif.
At the annual ASCO meeting, Margaret A. Tempero, M.D., deputy director of the University of California at San Francisco Comprehensive Cancer Center was elected president of ASCO and David H. Johnson, M.D., deputy director of the Vanderbilt-Ingram Cancer Center in Nashville, Tenn., will succeed her as president-elect. Paul A. Bunn Jr., M.D., immediate past president of ASCO, will remain a member of the Board of Directors.
Larry Norton, M.D., a past president of ASCO, has been elected chairman of ASCO’s Board of Directors. Norton is head of the Solid Tumor Division and the Norna A. Sarofim Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center, New York.
Items in "Awards, Appointments, Announcements" are compiled from notices received by the News section. Not all notices are used; all are edited.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||